 |
| CrossRef Text and Data Mining |
| Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
| Rapid deterioration of preexisting renal insufficiency after autologous mesenchymal stem cell therapy |
| Jun-Seop Kim, Jong-Hak Lee, Owen Kwon, Jang-Hee Cho, Ji-Young Choi, Sun-Hee Park, Chan-Duck Kim, Yong-Jin Kim, Yong-Lim Kim |
|
Kidney Res Clin Pract. 2017;36(2):200-204. Published online June 30, 2017 DOI: https://doi.org/10.23876/j.krcp.2017.36.2.200 |
|
Rapid deterioration of preexisting renal insufficiency after autologous mesenchymal stem cell therapy Kidney Research and Clinical Practice. 2017;36(2):200-204  Mesenchymal stem cell treatment for chronic renal failure Stem Cell Research & Therapy. 2014;5(4): Among mesenchymal stem cells: for the best therapy after ischemic stroke Stem Cell Research & Therapy. 2013;4(1): End-stage renal disease after high-dose carboplatinum in preparation of autologous stem cell transplantation Pediatric Transplantation. 2003;7(5):408-412 291. Phase 1 Human Trial of Autologous Mesenchymal Stem Cell Transplantation for the Treatment of Decompensated Cirrhosis Molecular Therapy. 2007;15:S110 Interferon-Gamma Modification of Mesenchymal Stem Cells: Implications of Autologous and Allogeneic Mesenchymal Stem Cell Therapy in Allotransplantation Stem Cell Reviews and Reports. 2014;10(3):351-375 Autologous adipose mesenchymal stem cell administration in arteriosclerosis and potential for anti-aging application: a retrospective cohort study Stem Cell Research & Therapy. 2020;11(1): Intrinsic Mesenchymal Stem Cell Dysfunction in Diabetes Mellitus: Implications for Autologous Cell Therapy Stem Cells and Development. 2017;26(14):1042-1053 Autologous mesenchymal stem cell therapy in behcet disease Cytotherapy. 2017;19(5):S10-S11 Systemic Autologous Mesenchymal Stem Cell Therapy for Immunomodulation in Resistant Myasthenia Gravis Cytotherapy. 2016;18(6):S14 |
